Blue Trust’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Other funds holding TAK
Blue Trust's TAK Position: Q3 2026 in Review
Blue Trust reduced its Takeda Pharmaceutical (TAK) stake by 53% in Q3 2026, selling an estimated $92K and leaving 4,609 shares worth $83.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1063.
Blue Trust first reported a position in TAK in Q2 2022 and has held it in 18 quarters since. The position peaked at $218K in Q2 2025. 337 funds tracked by Wall St. Rank hold TAK as of Q3 2026.
- Blue Trust held 4,609 shares of Takeda Pharmaceutical worth $83.8K as of Q3 2026.
- Blue Trust sold 5,198 Takeda Pharmaceutical shares in Q3 2026, an estimated $92K.
- Takeda Pharmaceutical made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #1063 holding.
- Blue Trust first reported a position in Takeda Pharmaceutical in Q2 2022 and has held it in 18 quarters since.
- Blue Trust's Takeda Pharmaceutical position peaked at $218K in Q2 2025.
- 337 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.